EN DE
STOCK COMPARISON

Abbott Laboratories vs Getinge AB ser. B: Fair Value & Quality

Both stocks run through our valuation models. Here is how Abbott Laboratories (ABT) and Getinge AB ser. B (GETI-B) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees Getinge AB ser. B as the less overvalued of the two: Abbott Laboratories trades at $108 versus a fair value of $74.79 (-31%), while Getinge AB ser. B trades at SEK 242 versus SEK 192 (-21%).
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$108
Fair Value$74.79
Quality67/100
Getinge AB ser. B
GETI-B.ST · SEK · Health Care
-21%
upside to fair value
overvalued
PriceSEK 242
Fair ValueSEK 192
Quality61/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Abbott LaboratoriesGetinge AB ser. B
Valuation
27.7×P/E (TTM)28.0×
3.89×P/S (TTM)1.67×
3.36×P/B1.93×
15.1×EV/EBITDA11.2×
1.47×PEG1.61×
−31.0%Fair value upside−20.5%
2.3%Dividend yield2.0%
$2.44Dividend per shareSEK 4.75
Profitability
13%Operating margin10%
1.19×EBIT margin trend (5Y)0.82×
12%Return on equity8%
6%Return on assets5%
Growth
8%Revenue growth (YoY)-11%
0.5%Avg. growth/yr (3Y)7.3%
5.1%Avg. growth/yr (5Y)3.2%
+10.5%Value creation/yr−3.3%
Balance & size
23.6×Interest coverage (EBIT/interest)7.1×
0.19×Debt / equity0.27×
$175BMarket cap$6B
healthyGrowth qualitymixed

Abbott Laboratories leads: 11 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Abbott Laboratoriesof which business quality 66 · market factors 52 Getinge AB ser. Bof which business quality 61 · market factors 73
ProfitabilityMargins and returns on capital today
50
40
Quality GrowthAre margins and returns improving?
47
53
CashflowEarnings quality: real cash, not paper profit
71
56
Fin. StrengthBalance sheet, leverage, solvency risk
80
64
InvestmentDisciplined investing over empire-building
65
92
Low VolatilityCalm price path (market factor)
83
79
MomentumPrice trend over the last 3–12 months (market factor)
42
67
52W MomentumDistance to the 52-week high (market factor)
33
77
Net IssuanceBuybacks instead of dilution
84
82

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyAbbott LaboratoriesPrice $108Getinge AB ser. BPrice SEK 242
DCF Models-33%below the price$73.01-22%below the priceSEK 189
Earnings-Based-73%below the price$29.42-60%below the priceSEK 96.66
Dividend Discount-63%below the price$39.73n/a
Multiples-35%below the price$70.72-15%close to the priceSEK 206
Asset-Based-81%below the price$20.05-68%below the priceSEK 77.58
Growth DCF-38%below the price$67.02-25%below the priceSEK 182
Economic Profit-65%below the price$37.49-47%below the priceSEK 129
Growth Earnings-35%below the price$70.25-31%below the priceSEK 167
Minimum-81%below the price$20.05-68%below the priceSEK 77.58
Maximum-33%below the price$73.01-15%close to the priceSEK 206
Median-51%below the price$53.37-31%below the priceSEK 167
Geometric mean-57%below the price$46.36-41%below the priceSEK 142

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Getinge AB ser. B: 20 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$108 = current price (white tick)
Getinge AB ser. B
Bear SEK 111Fair Value SEK 192Bull SEK 274
SEK 242 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-31% · above median

Getinge AB ser. B · Health Care

Quality score61 · above median
Fair value upside-21% · above median

Bottom line

As of Sep 5, 2026, Fair Value Calculator sees Getinge AB ser. B as the less overvalued of the two: Abbott Laboratories trades at $108 versus a fair value of $74.79 (-31%), while Getinge AB ser. B trades at SEK 242 versus SEK 192 (-21%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →
Abbott Laboratories · Getinge AB ser. B

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Abbott Laboratories

Abbott Laboratories vs UnitedHealth GroupEli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth Group

Related to Getinge AB ser. B

Merck & Company vs UnitedHealth GroupAstraZeneca vs UnitedHealth GroupThermo Fisher Scientific vs UnitedHealth GroupAmgen vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.